Before revision: Phase III trials were published in January 2023 on CVO+ resulted in a significantly higher rate of treatment success and that it was effective for the treatment of mild-to-moderate forms of COVID-19 .Efficacy and safety of CVO PLUS CURATIF capsules, Malagasy improved traditional medication for treating COVID-19 a randomized trial
After revision: Phase III trials were published in January 2023 on CVO+ resulted in a significantly higher rate of treatment success and that it was effective for the treatment of mild-to-moderate forms of COVID-19